医学
败血症
疾病
生物标志物
重症监护医学
内科学
生物
生物化学
作者
Yachana Kataria,Daniel G. Remick
标识
DOI:10.1007/978-1-0716-1488-4_16
摘要
Biomarkers have been used in sepsis to assist with the diagnosis of disease as well as determining the severity of disease, that is, prognosis. These biomarkers are based on the presence of discrete molecules within the blood. Unfortunately, in 2020, a single biomarker does not have sufficient sensitivity and specificity to definitively rule in or rule out sepsis. Biomarkers have shown better performance in animal models of disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI